Power3 Medical Products, Inc. (OTC:PWRM)previously has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc., a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy.
PWRM plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in November 2010.
In addition, PWRM has filed several patent applications for its NuroPro technology that are currently pending.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. The tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
For more information about this company please visit http://www.power3medical.com
Expedia Inc. (NASDAQ:EXPE) said that higher travel bookings, average hotel rates and advertising revenue helped its third-quarter net income jump 55 percent from a year earlier. The company, which operates Hotwire.com, Hotels.com, Tripadvisor and its namesake Expedia.com, said it earned $176.6 million, or 62 cents per share, for the quarter that ended Sept. 30. That’s up from $117 million, or 40 cents per share, in the same quarter last year.
Expedia, Inc., together with its subsidiaries, operates as an online travel company in the United States and internationally.
KLA-Tencor Corporation (NASDAQ:KLAC) previously reported first quarter net income of $154 million, or 91 cents a share, compared to $20 million, or 12 cents a share in the same period last year. Milpitas-based KLA-Tencor (NASDAQ:KLAC) reported revenue of $682 million, nearly double the year-ago quarter’s $343 million.
KLA-Tencor Corporation provides process control and yield management solutions for the semiconductor manufacturing and related microelectronics industries.
cInc. (NASDAQ:NIHD) previously reported market-beating quarterly results on strong subscriber growth in Brazil and said its 3G services launch in Mexico would start adding to revenue from 2012.
The company said it was on track to exceed its prior outlook for the full year as a dynamic Brazilian wireless industry, powered by a resilient job market and surging family incomes, accounted for more than half of its subscriber additions.
NII Holdings, Inc., through its subsidiaries, provides wireless communication services to businesses and individuals primarily in Mexico, Brazil, Argentina, Peru, and Chile.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).